Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Leniolisib for untreated activated phosphoinositide 3-kinase delta syndrome (APDS) in people 12 years and over.

Lookup NU author(s): Nicole O'ConnorORCiD, Dr Hangjian WuORCiD, Oleta WilliamsORCiD, Dr Cristina Fernandez-GarciaORCiD, Sola AkinboladeORCiD, Ayomikun OgunyemiORCiD, Sonia Garcia Gonzalez-MoralORCiD, Fiona BeyerORCiD, Dr Sarah RiceORCiD, Dr Nick MeaderORCiD

Downloads

Full text is not currently available for this publication.


Publication metadata

Author(s): O'Connor N, Wu H, Williams O, Fernandez-Garcia C, Akinbolade S, Ogunyemi A, Gonzalez-Moral SG, Beyer F, Rice S, Meader N

Publication type: Report

Publication status: Published

Series Title: Highly specialised technologies guidance

Year: 2025

Pages: 32

Online publication date: 25/04/2025

Acceptance date: 25/04/2025

Report Number: HST33

Institution: National Institute for Health and Care Excellence

Place Published: Manchester

URL: https://www.nice.org.uk/guidance/HST33

Notes: Produced by Newcastle NIHR Technology Assessment Review (TAR) Team, Newcastle University. [ID6130]. ISBN 9781473169395.


Share